Skip to main content
. 2019 Jun 4;20(11):2742. doi: 10.3390/ijms20112742

Figure 1.

Figure 1

Patient-derived human cardiac progenitor cells (CPCs) can be isolated and selected for expansion as clones that express markers of early stage progenitors. A schematic representation of the cardiovascular differentiation pathway is shown in (A). These cells are isolated based on their co-expression of high levels of islet-1 and low levels of c-kit (B). Cells at this early stage express the glycoprotein CD56 (C).